The Prognostic Impact of Tumor Size and <i>BRAF</i> Mutational Status in Middle Eastern Differentiated Thyroid Cancer
Tumor size is an independent predictor of EFS in Middle Eastern patients with DTC, regardless of BRAF mutational status.
Authors
- Khawla S. Al‐Kuraya (ORCID: https://orcid.org/0000-0002-4126-3419)
- Zeeshan Qadri (ORCID: https://orcid.org/0000-0003-4026-8987)
- Nabil Siraj
- Abdul K. Siraj (ORCID: https://orcid.org/0000-0003-2162-6857)
- Fouad Al‐Dayel (ORCID: https://orcid.org/0000-0001-6175-9051)
- Saif S. Al-Sobhi
- Maha Al‐Rasheed (ORCID: https://orcid.org/0000-0001-6668-2874)
- Wael Haqawi
- Sandeep Kumar Parvathareddy
Institutions
- King Faisal Specialist Hospital & Research Centre (SA)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2024-10-18
- DOI
- https://doi.org/10.1210/clinem/dgae740
- Citations
- 1
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.36